CDK9 inhibitors (Vichem Chemie/Rega Institute/ViroStatics)

N/A

Report date: 2025/01/26 17:46:14
NME

Base Information

Drug NameCDK9 inhibitors (Vichem Chemie/Rega Institute/ViroStatics)
Drug Alias NameCDK-9 inhibitors (Vichem Chemie/Rega Institute)VC-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 9 inhibitors
TargetsCyclin-dependent kinase 9
Therapy Area/IndicationsSmall Cell Lung CarcinomaHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumItalyHungary
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVichem Chemie
China Registration ClassN/A

Develop Information

Active CompaniesVirostatics SrlVichem ChemieRega Institute for Medical Research
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung CarcinomaHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A